The Lifetime Genomics Risk Assessment is a polygenic screening test that provides your clinical team with contextual information about a patient's polygenic risk of developing medical conditions such as heart disease, diabetes, or certain types of cancer. There are many benefits to integrating polygenic testing into your clinical routine, including but not limited to:
- Early detection of at risk patients: Polygenic risk scores can help identify patients who are at higher risk for developing certain conditions, which may allow for earlier diagnosis and treatment. This can lead to improved health outcomes and lower healthcare costs for your patient population.
- Improved patient engagement: Polygenic risk scores can help provide patients with a better understanding of their personal health risks and motivate them to take steps to reduce their risk of developing certain diseases. This can help with adherence to necessary lifestyle modifications that affect long term patient health.
- Precision medicine: Polygenic risk scores are becoming increasingly useful in the field of precision medicine, which aims to provide personalized healthcare based on an individual's unique genetic makeup, environment, and lifestyle. Knowing a patient’s polygenic risk score for certain diseases can help healthcare providers tailor preventative strategies and treatment plans to the individual.
For more information about the clinical implementation of PRS, check out our Ask a GC blog posts here